Izhar, M.; Al Gharyani, M.; Kattaa, A.H.; Cardona, J.J.; Jain, R.P.; Shaghaghian, E.; Hori, Y.S.; Lam, F.C.; Abu Reesh, D.; Emrich, S.C.;
et al. Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases. Pharmaceutics 2025, 17, 899.
https://doi.org/10.3390/pharmaceutics17070899
AMA Style
Izhar M, Al Gharyani M, Kattaa AH, Cardona JJ, Jain RP, Shaghaghian E, Hori YS, Lam FC, Abu Reesh D, Emrich SC,
et al. Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases. Pharmaceutics. 2025; 17(7):899.
https://doi.org/10.3390/pharmaceutics17070899
Chicago/Turabian Style
Izhar, Muhammad, Mohamed Al Gharyani, Ahed H. Kattaa, Juan J. Cardona, Ruchit P. Jain, Elaheh Shaghaghian, Yusuke S. Hori, Fred C. Lam, Deyaaldeen Abu Reesh, Sara C. Emrich,
and et al. 2025. "Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases" Pharmaceutics 17, no. 7: 899.
https://doi.org/10.3390/pharmaceutics17070899
APA Style
Izhar, M., Al Gharyani, M., Kattaa, A. H., Cardona, J. J., Jain, R. P., Shaghaghian, E., Hori, Y. S., Lam, F. C., Abu Reesh, D., Emrich, S. C., Ustrzynski, L., Tayag, A., Lesniak, M. S., Chang, S. D., & Park, D. J.
(2025). Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases. Pharmaceutics, 17(7), 899.
https://doi.org/10.3390/pharmaceutics17070899
